[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Pemphigus Vulgaris - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Pemphigus Vulgaris - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pemphigus Vulgaris development. The report provides ...

January 2020 60 pages

Peptic Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Peptic Ulcers. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Periodontal Disease - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Periodontal Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Periodontal Disease development. The report provides ...

January 2020 60 pages

Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... and Phase III products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Peripheral Neuropathic Pain. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Peripheral Neuropathic Pain - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Peripheral Neuropathic Pain The report also ...

January 2020 60 pages

Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Peripheral T-Cell Lymphomas (PTCL). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Phenylketonuria (PKU). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Phenylketonuria (PKU) - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Phenylketonuria (PKU) - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Phenylketonuria (PKU) development. The report provides ...

January 2020 60 pages

Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pituitary ACTH Hypersecretion (Cushing's Disease) The report also ...

January 2020 60 pages

Plague - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Plague - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Plague development. The report provides detailed ...

January 2020 60 pages

Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Plaque Psoriasis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Plaque Psoriasis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Plaque Psoriasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Plaque Psoriasis development. The report provides ...

January 2020 60 pages

Pleural Effusion - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Pleural Effusion - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pleural Effusion development. The report provides ...

January 2020 60 pages

Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Polycystic Kidney Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Polycystic Kidney Disease - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Polycystic Kidney Disease The report also ...

January 2020 60 pages

Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Polycythemia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Polycythemia - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Polycythemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Polycythemia development. The report provides detailed ...

January 2020 60 pages

Polymyositis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Polymyositis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Polymyositis development. The report provides detailed ...

January 2020 90 pages

Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Pompe Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Porphyria. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Porphyria - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Porphyria - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Porphyria development. The report provides detailed ...

January 2020 60 pages

Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Post Menopausal Osteoporosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Postherpetic Neuralgia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Postherpetic Neuralgia - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Postherpetic Neuralgia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Postherpetic Neuralgia development. The report provides ...

January 2020 60 pages

Postmenopausal Vaginal Atrophy - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Postmenopausal Vaginal Atrophy The report also ...

January 2020 60 pages

Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Post-Traumatic Stress Disorder (PTSD). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Pouchitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Premature Ejaculation. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Premature Ejaculation - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Premature Ejaculation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Premature Ejaculation development. The report provides ...

January 2020 60 pages

Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Premature Labor (Tocolysis). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Premature Labor (Tocolysis) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Premature Labor (Tocolysis) The report also ...

January 2020 60 pages

Pressure Ulcers - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Pressure Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pressure Ulcers development. The report provides ...

January 2020 120 pages

Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Primary Biliary Cirrhosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Primary Immune Deficiency (PID). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Primary Immune Deficiency (PID) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Primary Immune Deficiency (PID) The report also ...

January 2020 60 pages

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Primary Progressive Multiple Sclerosis (PPMS) The report also ...

January 2020 90 pages

Progressive Multifocal Leukoencephalopathy - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Progressive Multifocal Leukoencephalopathy The report also ...

January 2020 60 pages

Psoriatic Arthritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Psoriatic Arthritis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Pulmonary Arterial Hypertension. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Pulmonary Embolism. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Pyelonephritis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Pyelonephritis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Pyelonephritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pyelonephritis development. The report provides detailed ...

January 2020 90 pages

Radiation Toxicity - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Radiation Toxicity - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Radiation Toxicity development. The report provides ...

January 2020 60 pages

Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Raynauds Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Raynauds Disease - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Raynauds Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Raynauds Disease development. The report provides ...

January 2020 60 pages

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... Phase III products for Recurrent Head And Neck Cancer Squamous Cell Carcinoma. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2020

 US$ 1,250.00

... chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Recurrent Head And Neck Cancer Squamous Cell Carcinoma The report also ...

January 2020 60 pages

Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Relapsed Chronic Lymphocytic Leukemia (CLL). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Relapsed Chronic Lymphocytic Leukemia (CLL) The report also ...

January 2020 60 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1